Drugmakers move to intervene in 340B rebate pilot lawsuit
Oct 11, 2026 – Oct 20, 2026
-
Hospitals sue HHS to block 340B rebate pilot scheduled for January 2027
The American Hospital Association, the Maine Hospital Association, and four safety-net hospitals filed suit October 9 in federal court in Maine to stop a 340B rebate pilot that would require hospitals to pay full drug prices and wait for manufacturer rebates, with AHA estimating added administrative costs above $1 billion a year.
Read this issue → -
Drugmakers seek to join 340B rebate suit
AbbVie, Bristol Myers Squibb, Boehringer Ingelheim and PhRMA moved to intervene in the hospitals' Maine suit against the 340B rebate pilot covering 21 drugs from 10 manufacturers, set to start January 1, 2027.
Read this issue → -
Drugmakers move to intervene in 340B rebate pilot lawsuit
AbbVie, Bristol-Myers Squibb and Boehringer Ingelheim filed on October 14 to join the hospitals' suit against the HHS 340B rebate pilot, and PhRMA filed its own motion, citing $40 million in duplicate-discount losses at Bristol-Myers.
Read this issue →